Osimertinib in EGFR Mutation-Positive Advanced NSCLC
- PMID: 29590540
- DOI: 10.1056/NEJMc1801669
Osimertinib in EGFR Mutation-Positive Advanced NSCLC
Comment on
-
Osimertinib in EGFR Mutation–Positive Advanced NSCLC.N Engl J Med. 2018 Mar 29;378(13):1261. doi: 10.1056/NEJMc1801669. N Engl J Med. 2018. PMID: 29595922 No abstract available.
-
Osimertinib in EGFR Mutation–Positive Advanced NSCLC.N Engl J Med. 2018 Mar 29;378(13):1261-2. doi: 10.1056/NEJMc1801669. N Engl J Med. 2018. PMID: 29595923 No abstract available.
-
Osimertinib in EGFR Mutation–Positive Advanced NSCLC.N Engl J Med. 2018 Mar 29;378(13):1262. doi: 10.1056/NEJMc1801669. N Engl J Med. 2018. PMID: 29595924 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous